Connect with us

archive

Bayer to Acquire Merck’s Consumer Business Unit for $14.2 Billion

Bayer to Acquire Merck’s Consumer Business Unit for $14.2 Billion (Bloomberg)

Bayer AG’s (BAYN) deal to purchase Merck & Co’s consumer products unit for $14.2 billion will be the second-largest acquisition in the Germany-based company’s history. And it follows the Novartis/GlaxoSmithKline whopper of a deal in Big Pharma announced just weeks ago. Even though Bayer’s paying more than 20 times earnings for Merck’s business, and many feel that’s too much, others like the deal, including Ulrich Huwald of Warburg Research: “Strategically, this is a consistent step for Bayer. The have a very strong brand, a clearly positive position in the over-the-counter business.” However, investors appear to be lining up opposite Ulrich on the deal, as BAYN shares are down since the announcement. What do you think?

Newsletter Signup.

Sign up to the Human Events newsletter

Advertisement
Advertisement

TRENDING NOW:

The Divided State of Britain.

CULTURE

Gulf of Oman 'attack': Oil tankers on fire amid rising tensions between Iran and rivals Gulf of Oman 'attack': Oil tankers on fire amid rising tensions between Iran and rivals

Don’t Rush to War with Iran Over Some Tankers.

U.S. POLITICS

Democracy Dies with Chinese Propaganda.

CULTURE

Brooklyn Bridge, 1890s Brooklyn Bridge, 1890s

The DNC Sold The Brooklyn Bridge To The FBI.

U.S. POLITICS

archive

Bayer to Acquire Merck??s Consumer Business Unit for $14.2 Billion

Bayer AG’s (BAYN) deal to purchase Merck & Co??s consumer products unit for $14.2 billion will be the second-largest acquisition in the Germany-based company??s history.

Bayer to Acquire Merck??s Consumer Business Unit for $14.2 Billion (Bloomberg)

Bayer AG’s (BAYN) deal to purchase Merck & Co??s consumer products unit for $14.2 billion will be the second-largest acquisition in the Germany-based company??s history. And it follows the Novartis/GlaxoSmithKline whopper of a deal in Big Pharma announced just weeks ago. Even though Bayer??s paying more than 20 times earnings for Merck??s business, and many feel that??s too much, others like the deal, including Ulrich Huwald of Warburg Research: ??Strategically, this is a consistent step for Bayer. The have a very strong brand, a clearly positive position in the over-the-counter business.? However, investors appear to be lining up opposite Ulrich on the deal, as BAYN shares are down since the announcement. What do you think?

Newsletter Signup.

Sign up to the Human Events newsletter

Written By

TRENDING NOW:

The Divided State of Britain.

CULTURE

Gulf of Oman 'attack': Oil tankers on fire amid rising tensions between Iran and rivals Gulf of Oman 'attack': Oil tankers on fire amid rising tensions between Iran and rivals

Don’t Rush to War with Iran Over Some Tankers.

U.S. POLITICS

Democracy Dies with Chinese Propaganda.

CULTURE

Brooklyn Bridge, 1890s Brooklyn Bridge, 1890s

The DNC Sold The Brooklyn Bridge To The FBI.

U.S. POLITICS

Connect
Newsletter Signup.

Sign up to the Human Events newsletter